Ty Triston Dickerson

Dr. Bollo is board-certified in neurosurgery and pediatric neurosurgery. His primary focus is the surgical treatment of seizures in children, and he serves as the Division Chief of the Pediatric Neurosurgery Program as well as the surgical director of the pediatric epilepsy program at Primary Children's Hospital. Dr. Bollo introduced laser ablation and robotic epilepsy surgery including stereo EEG (robotic SEEG) to Utah and the Intermountain West, performed the first robotic surgery at Primary Children's Hospital, and is committed to identifying the least invasive surgical treatment with the highest possible efficacy for every child suffering from seizures. Dr. Bollo is among the busiest pediatric epilepsy surgeons in country, and is an expert in brain mapping in children, temporal and extra-temporal lobectomy, functional hemispherectomy, laser ablation, and awake craniotomy. He also specializes in the treatment of brain and spinal cord tumors, spasticity including selective dorsal rhizotomy, surgery for fetal anomalies including spina bifida, pediatric spine surgery, and neuroendoscopy.

David L Rothberg, MD. - His area of clinical expertise includes pelvic and acetabular fractures, nonunion and malunion, peri-articular fractures, pediatric orthopaedic trauma, and post-traumatic reconstruction. He is an Associate Professor and the Residency Program Director in the Department of Orthopaedics at the University of Utah and the Orthopaedic Trauma Liaison for Primary Children's Hospital, He has a clinical practice at the University of Utah Hospital and Clinics and Primary Children's Hospital. Dr. Rothberg completed his residency in Orthopaedic Surgery at the University of Utah and fellowship in Orthopaedic Trauma at the University of California at Davis. He is currently a member of the American Academy of Orthopaedic Surgeons, the American Othopaedic Association, the Orthopaedic Trauma Association and both a member and faculty of AO Trauma.

Dr. Dolan received his medical degree from the University of Washington and completed his Pediatric residency at Seattle Children´s Hospital. He went on to pursue his Pediatric Hematology and Oncology Fellowship and advanced fellowship in cellular/immunotherapy and bone marrow transplant at the Children’s Hospital of Philadelphia. He joined the faculty of the University of Utah in 2021 as an Assistant Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. Dr. Dolan’s clinical interests include the treatment of pediatric disorders requiring bone marrow transplant. He has an emphasis on high-risk hematologic malignancies and cellular therapy designed to reduce toxicity in patients with relapsed and refractory disease. His primary research focuses on outcomes of children treated with cellular/immunotherapy products. He also has an interest in understanding the emotional and spiritual challenges that arise as part of the journey for patients and families diagnosed with cancer.